Cargando…
Evaluation of Glycosylated PTGS2 in Colorectal Cancer for NSAIDS-Based Adjuvant Therapy
Observational/retrospective studies indicate that prostaglandin-endoperoxide synthase-2 (PTGS2) inhibitors could positively affect colorectal cancer (CRC) patients’ survival after diagnosis. To obtain an acceptable cost/benefit balance, the inclusion of PTGS2 inhibitors in the adjuvant setting needs...
Autores principales: | Venè, Roberta, Costa, Delfina, Augugliaro, Raffaella, Carlone, Sebastiano, Scabini, Stefano, Casoni Pattacini, Gianmaria, Boggio, Maurizio, Zupo, Simonetta, Grillo, Federica, Mastracci, Luca, Pitto, Francesca, Minghelli, Simona, Ferrari, Nicoletta, Tosetti, Francesca, Romairone, Emanuele, Mingari, Maria C., Poggi, Alessandro, Benelli, Roberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7140631/ https://www.ncbi.nlm.nih.gov/pubmed/32168749 http://dx.doi.org/10.3390/cells9030683 |
Ejemplares similares
-
SB202190 Predicts BRAF-Activating Mutations in Primary Colorectal Cancer Organoids via Erk1-2 Modulation
por: Costa, Delfina, et al.
Publicado: (2023) -
Targeting the Epidermal Growth Factor Receptor Can Counteract the Inhibition of Natural Killer Cell Function Exerted by Colorectal Tumor-Associated Fibroblasts
por: Costa, Delfina, et al.
Publicado: (2018) -
Celecoxib increases EGF signaling in colon tumor associated fibroblasts, modulating EGFR expression and degradation
por: Venè, Roberta, et al.
Publicado: (2015) -
Human Gut-Associated Natural Killer Cells in Health and Disease
por: Poggi, Alessandro, et al.
Publicado: (2019) -
A Meta-Analysis of PTGS1 and PTGS2 Polymorphisms and NSAID Intake on the Risk of Developing Cancer
por: Nagao, Mai, et al.
Publicado: (2013)